Project Grant R44AT013552
- This federal Project Grant award of $241,102, provided by the National Center for Complementary and Integrative Health (NCCIH) under the Research and Training in Complementary and Integrative Health program (CFDA 93.213), supports the development of an artificial intelligence-based recommendation engine for Art Pharmacy's social prescribing platform. Art Pharmacy is an arts-based social prescribing company that provides personalized arts prescriptions to help patients at risk of or...
- The National Center for Complementary and Integrative Health (NCCIH), part of the U.S. Department of Health and Human Services, awarded a $306,872 Project Grant under the Research and Training in Complementary and Integrative Health program (CFDA 93.213) to Evoquant LLC. The funding supports the development of the "BioPredictor" platform, an innovative artificial intelligence and multi-omics system designed to enhance natural product drug discovery and target selection. The project...
- The National Center for Complementary and Integrative Health (NCCIH), part of the U.S. Department of Health and Human Services, has awarded a $731,961 Project Grant under the "Research and Training in Complementary and Integrative Health" program (CFDA 93.213) to the University of Cincinnati. The 5-year grant, effective April 17, 2025, will fund a study examining the effects of N-acetylcysteine (NAC) and Mindfulness-Based Cognitive Therapy (MBCT) on mild depression in youth aged 15-24....
- The National Center for Complementary and Integrative Health (NCCIH), a component of the U.S. Department of Health and Human Services, awarded a $269,468 Project Grant under the "Research and Training in Complementary and Integrative Health" program (CFDA 93.213) to Brigham & Women's Hospital Inc. The grant, titled "HARMONIZED HEALING: PERSONALIZED MUSIC INTERVENTIONS TO ADDRESS CHRONIC PAIN IN PEOPLE LIVING WITH HIV", will fund research to investigate the use of...
- This federal Project Grant award from the National Center for Complementary and Integrative Health (NCCIH), under the Research and Training in Complementary and Integrative Health program (CFDA 93.213), provides $706,367 to New York University to conduct a feasibility trial testing the use of a music listening intervention for mental health recovery in chronic stroke patients. The key product or service to be delivered is the development and testing of a remote, music-based intervention guided...
- The National Center for Complementary and Integrative Health (NCCIH), within the U.S. Department of Health and Human Services, awarded a $337,675 Project Grant under the Research and Training in Complementary and Integrative Health program (CFDA 93.213) to The Spaulding Rehabilitation Hospital Corporation located in Charlestown, Massachusetts. The project aims to enhance therapeutic outcomes for patients with fibromyalgia by incorporating Theory of Mind (ToM) training into clinical practice. The...
- The National Institutes of Health National Center for Complementary and Integrative Health awarded New York University $785,637 under the Research and Training in Complementary and Integrative Health program (CFDA 93.213) from June 2021 through May 2025. This Cooperative Agreement will support the development and pilot testing of telephone-delivered and video-based Mindfulness-Based Cognitive Therapy (MBCT) protocols for patients with migraine headaches and depressive symptoms. Specifically, the...
- The National Center for Complementary and Integrative Health (NCCIH), part of the Department of Health and Human Services, awarded a $170,604 Project Grant under the Research and Training in Complementary and Integrative Health program (CFDA 93.213) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH). The grant funds the development, refinement, and pilot testing of the "Resilient Together-ALS (RT-ALS)" intervention, a mind-body and meaning-based...
- The National Institute of Mental Health (NIMH) awarded a $780,698 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to the University of Wisconsin - Madison. The 4-year grant aims to optimize the integration of human and digital support in a meditation app to address the public health burden of depression and anxiety. The project will examine the effects of adding introductory coaching, on-demand email-based coaching, and digital prompts to the Healthy Minds Program...
- This Project Grant award from the National Center for Complementary and Integrative Health (NCCIH), under the federal Research and Training in Complementary and Integrative Health program (CFDA 93.213), will fund a feasibility clinical trial to develop and evaluate a Psilocybin-Assisted Cognitive Behavioral Therapy (PA-CBT) protocol for treating major depressive disorder. The $236,250 award, granted on December 17, 2024, supports a 3-year study to refine and optimize the PA-CBT approach, and...
The National Center for Complementary and Integrative Health (NCCIH), part of the U.S. Department of Health and Human Services, awarded a $293,920 Project Grant under the Research and Training in Complementary and Integrative Health program (CFDA 93.213) to SocialRx Inc. (dba Art Pharmacy). The grant funds the design, development, and beta testing of a minimum viable product (MVP) for a digital companion app that will provide personalized recommendations and support for youth to access arts-based social prescriptions to address mental health challenges. The app will complement Art Pharmacy's existing care navigation services, offering a mobile-responsive experience to guide users from intake to selection and attendance of arts and cultural events. The goal is to increase motivation for in-person participation, enhance social connections, and support self-reported improvements in mental well-being among youth. This Phase I effort will be followed by a randomized controlled trial in Phase II to evaluate the digital companion's efficacy.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $293.9k | 9/8/25 |